Numeral Limited (JSE:XII)

South Africa · Delayed Price · Currency is ZAR · Price in ZAc

30.00

+3.00 (11.11%)

Oct 19, 2026, 1:33 PM SAST

Market Cap	136.27M -36.7%
Revenue (ttm)	36.62M -14.8%
Net Income	445.39K -84.4%
EPS	0.00 -98.4%
Shares Out	n/a
PE Ratio	275.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Open	30.00
Previous Close	27.00
Day's Range	30.00 - 30.00
52-Week Range	10.00 - 90.00
Beta	0.01
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 19, 2026

About Numeral

Numeral Limited, an investment holding company, engages in biotech, health and pharmaceutical, and financial businesses in Mauritius. It operates through Biotechnology and Healthcare Services, Financial Services, Investment Activities and Asset Management segments. It also provides legal support, human resources, technology support, financial services, corporate finance, and marketing, as well as business acquisition solutions. In addition, it offers stem-cell harvesting, storage, and related healthcare and biotechnology activities; and asset m... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2010

Country Mauritius

Stock Exchange Johannesburg Stock Exchange

Ticker Symbol XII

Financial Performance

In fiscal year 2026, Numeral's revenue was $2.20 million, an increase of 29.98% compared to the previous year's $1.69 million. Earnings were $79,939, a decrease of -52.64%.

Financial numbers in USD Financial Statements